Syneos Health (FRA:8IN) Interest Coverage

: 1.40 (As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Syneos Health's Operating Income for the three months ended in Jun. 2023 was €49 Mil. Syneos Health's Interest Expense for the three months ended in Jun. 2023 was €-35 Mil. Syneos Health's interest coverage for the quarter that ended in Jun. 2023 was 1.40. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Syneos Health's Interest Coverage or its related term are showing as below:

FRA:8IN' s Interest Coverage Range Over the Past 10 Years
Min: 0.72 Med: 3.01 Max: 14.32
Current: 3.08

FRA:8IN's Interest Coverage is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 12.375 vs FRA:8IN: 3.08

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Syneos Health Interest Coverage Historical Data

The historical data trend for Syneos Health's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Syneos Health Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Interest Coverage

Get a 7-Day Free Trial

2.11

2.16

3.54

5.20

5.58

Syneos Health Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Interest Coverage	Get a 7-Day Free Trial															6.94	5.72	4.48	1.69	1.40

Competitive Comparison

For the Diagnostics & Research subindustry, Syneos Health's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syneos Health Interest Coverage Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Syneos Health's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Syneos Health's Interest Coverage falls into.

Syneos Health Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Syneos Health's Interest Coverage for the fiscal year that ended in Dec. 2022 is calculated as

Here, for the fiscal year that ended in Dec. 2022, Syneos Health's Interest Expense was €-78 Mil. Its Operating Income was €434 Mil. And its Long-Term Debt & Capital Lease Obligation was €2,672 Mil.

Interest Coverage	=	-1	*	Operating Income (A: Dec. 2022 )	/	Interest Expense (A: Dec. 2022 )
	=	-1	*	434.082	/	-77.783
	=	5.58

Syneos Health's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

Here, for the three months ended in Jun. 2023, Syneos Health's Interest Expense was €-35 Mil. Its Operating Income was €49 Mil. And its Long-Term Debt & Capital Lease Obligation was €2,609 Mil.

Interest Coverage	=	-1	*	Operating Income (Q: Jun. 2023 )	/	Interest Expense (Q: Jun. 2023 )
	=	-1	*	48.792	/	-34.96
	=	1.40

The higher the ratio, the stronger the company's Financial Strength is.

Syneos Health (FRA:8IN) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Syneos Health Interest Coverage Related Terms

Thank you for viewing the detailed overview of Syneos Health's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

Syneos Health (FRA:8IN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Syneos Health Inc (FRA:8IN) » Definitions » Interest Coverage

Comparable Companies

Traded in Other Exchanges

N/A

Address

1030 Sync Street, Morrisville, NC, USA, 27560-5468

Website

https://www.syneoshealth.com

Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.

Syneos Health (FRA:8IN) Headlines

No Headlines